Capricor Therapeutics (CAPR) Non Operating Income (2010 - 2026)

Capricor Therapeutics' Non Operating Income history runs 17 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 378.82% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $5.3 million (up 140.84% YoY), while the FY2025 annual figure was $3.1 million, up 47.77% from the prior year.
• Non Operating Income was $2.8 million for Q1 2026 at Capricor Therapeutics, up from -$1.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.8 million in Q1 2026 to a low of -$1.0 million in Q4 2025.
• Historically, Non Operating Income has averaged $617477.4 across 5 years, with a median of $471829.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income surged 2998.53% in 2023, then slumped 274.34% in 2025.
• A 5-year view of Non Operating Income shows it stood at $345433.0 in 2022, then jumped by 50.3% to $519203.0 in 2023, then climbed by 11.95% to $581238.0 in 2024, then plunged by 274.34% to -$1.0 million in 2025, then soared by 379.43% to $2.8 million in 2026.
• The last three Non Operating Income figures came in at $2.8 million (Q1 2026), -$1.0 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.